Age-related Macular Disease: How to assess the retina using scanning laser techniques?

Aging Clinical and Experimental Research

Volumn 17, Issue 6, 2005, Pages 435-444

  Bellmann, Caren ^a,b   Kabanarou, Stamatina A ^a   Sahel, José A ^a,b   Rubin, Gary S ^a   Fitzke, Frederick W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

Author keywords

Age related macular disease; Fundus autofluorescence; Imaging; Optical coherence tomography; Scanning laser ophthalmoscopy; Visual rehabilitation

Indexed keywords

BLINDNESS; CLINICAL ASSESSMENT; FLUORESCENCE ANGIOGRAPHY; FUNCTIONAL ASSESSMENT; HUMAN; IMAGING; INFRARED RADIATION; PATHOGENESIS; PIGMENT EPITHELIUM; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; SCANNING LASER OPHTHALMOSCOPY; SCOTOMA; SUBRETINAL NEOVASCULARIZATION; AGED; AGING; LASER; OPHTHALMOSCOPE; PATHOLOGY; RETINA; RETINA MACULA DEGENERATION;

DIAGNOSTIC AGENT;

AGED; AGING; HUMANS; LASERS; MACULAR DEGENERATION; OPHTHALMOSCOPES; RETINA;

EID: 33744992528     PISSN: 15940667     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03327409     Document Type: Review

References (109)

1. Hyman LG, Lilienfeld AM, Ferris FL 3rd, Fine SL. Senile macular degeneration: a case-control study. Am J Epidemiol 1983; 118: 213-27.
2. Bird AC. Age-related macular disease. Br J Ophthalmol 1996; 80: 2-3.
3. Bird AC. The Bowman lecture. Towards an understanding of age-related macular disease. Eye 2003; 17: 457-66.
4. Chopdar A, Chakravarthy U, Verma D. Age related macular degeneration. BMJ 2003; 326: 485-8.
5. Wormald R, Evans J. Registration of blind and partially sighted people. Br J Ophthalmol 1994; 78: 733-4.
6. Bellmann C, Jorzik J, Spital G, Unnebrink K, Pauleikhoff D, Holz FG. Symmetry of bilateral lesions in geographic atrophy in patients with age-related macular degeneration. Arch Ophthalmol 2002; 120: 579-84.
7. Holz FG, Wolfensberger TJ, Piguet B, et al. Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 1994; 101: 1522-8.
8. Lavin MJ, Eldem B, Gregor ZJ. Symmetry of disciform scars in bilateral age-related macular degeneration. Br J Ophthalmol 1991; 75: 133-6.
9. Grizzard SW, Arnett D, Haag SL. Twin study of age-related macular degeneration. Ophthalmic Epidemiol 2003; 10: 315-22.
10. Hammond CJ, Webster AR, Snieder H, Bird AC, Gilbert CE, Spector TD. Genetic influence on early age-related maculopathy: a twin study. Ophthalmology 2002; 109: 730-6.
11. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res 2001; 20: 227-53.
12. Smith W. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001; 108: 697-704.
13. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8. Arch Ophthalmol 2001; 119: 1417-36.
14. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367-74.
15. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol 1988; 32: 375-413.
16. Timberlake GT, Mainster MA, Peli E, Augliere RA, Essock EA, Arend LE. Reading with a macular scotoma: I. Retinal location of scotoma and fixation area. Invest Ophthalmol Vis Sci 1986; 27: 1137-47.
17. Whittaker SG, Budd J, Cummings RW. Eccentric fixation with macular scotoma. Invest Ophthalmol Vis Sci 1988; 29: 268-78.
18. Trauzettel-Klosinski S, Teschner C, Tornow R, Zrenner E. Reading strategies in normal subjects and in patients with macular scotoma assessed by two new methods of registration. Neuroophthalmology 1994; 14: 15-30.
19. Staurenghi G, Orzalesi N, La Capria A, Aschero M. Laser treatment of feeder vessels in subfoveal choroidal neovascular membranes: a revisitation using dynamic indocyanine green angiography. Ophthalmology 1998; 105: 2297-305.
20. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of age-related macular degeneration with photodynamic therapy. Arch Ophthalmol 1999; 117: 1329-45.
21. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization- verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001; 131: 541-60.
22. Bressler NM. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2. Arch Ophthalmol 2001; 119: 198-207.
23. Newsom RS, McAlister JC, Saeed M, McHugh JD. Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularisation. Br J Ophthalmol 2001; 85: 173-8.
24. Algvere PV, Libert C, Lindgarde G, Seregard S. Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-up. Acta Ophthalmol Scand 2003; 81: 110-7.
25. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol 1994; 232: 707-16.
26. Binder S, Stolba U, Krebs I, et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: a pilot study. Am J Ophthalmol 2002; 133: 215-25.
27. Machemer R, Steinhorst UH. Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol 1993; 231: 635-41.
28. Eckardt C, Eckardt U, Conrad HG. Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1999; 237: 313-25.
29. Radiation Therapy for Age-related Macular Degeneration (RAD) Study group. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Radiation Therapy for Age-related Macular Degeneration. Ophthalmology 1999; 106: 2239-47.
30. Hart PM, Chakravarthy U, Mackenzie G, et al. Visual outcomes in the subfoveal radiotherapy study: a randomized controlled trial of teletherapy for age-related macular degeneration. Arch Ophthalmol 2002; 120: 1029-38.
31. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust NZ J Ophthalmol 1998; 26: 277-81.
32. Pharmacological Therapy for Macular Degeneration Study Group. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Arch Ophthalmol 1997; 115: 865-72.
33. D'Amato RJ, Loughnan MS, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 1994; 91: 4082-5.
34. D'Amico DJ, Goldberg MF, Hudson H, et al. Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: twelve-month clinical outcomes. Ophthalmology 2003; 110: 2372-83.
35. Gillies MC, Simpson JM, Luo W, et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol 2003; 121: 667-73.
36. Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 2003; 110: 979-86.
37. Webb RH, Hughes GW, Pomerantzeff O. Flying spot TV ophthalmoscope. Appl Opt 1980; 19: 2991-7.
38. Webb RH, Hughes GW, Delori FC. Confocal scanning laser ophthalmoscope. Appl Opt 1987; 26: 1492-9.
39. Fletcher DC, Schuchard RA. Preferred retinal loci relationship to macular scotomas in a low-vision population. Ophthalmology 1997; 104: 632-8.
40. Fletcher DC, Schuchard RA. Relative locations of macular scotomas near PRL: effect on low-vision reading. J Rehabil Res Dev 1999; 36: 356-64.
41. Timberlake GT, Mainster MA, Webb RH, Hughes GW, Trempe CL. Retinal localization of scotomata by scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci 1982; 22: 91-7.
42. Rohrschneider K, Fendrich T, Becker M, Krastel H, Kruse FE, Völcker HE. Static fundus perimetry using the scanning laser ophthalmoscope with an automated threshold strategy. Graefes Arch Clin Exp Ophthalmol 1995; 233: 743-9.
43. Sabates NR, Crane WG. Scanning laser ophthalmoscope macular perimetry in the evaluation of submacular surgery. Retina 1996; 16: 296-304.
44. Sunness JS, Applegate CA, Haselwood D, Rubin GS. Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease. Ophthalmology 1996; 103: 1458-66.
45. Sunness JS, Schuchard RA. Landmark-driven fundus perimetry using the scanning laser ophthalmoscope. Invest Ophthalmol Vis Sci 1995; 36: 1863-74.
46. Bischoff PM, Niederberger HJ, Török B, Speiser P. Simultaneous indocyanine green and fluorescein angiography. Retina 1995; 15: 91-9.
47. Bartsch DU, Weinreb RN, Zinser G, Freeman WR. Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol 1995; 120: 642-51.
48. Dithmar S, Bellmann C, Holz FG, Völcker HE. Konfokale Scanning-Laser-Indozyaningrünangiographie klassischer choroidaler Neovaskularisationen. Ophthalmologe 1997; 94: 343-7.
49. Holz FG, Bellmann C, Rohrschneider K, Burk RO, Völcker HE. Simultaneous confocal scanning laser fluorescein and indocyanine green angiography. Am J Ophthalmol 1998; 125: 227-36.
50. Szweda PA, Camouse M, Lundberg KC, Oberley TD, Szweda LI. Aging, lipofuscin formation, and free radical-mediated inhibition of cellular proteolytic systems. Ageing Res Rev 2003; 2: 383-405.
51. Schütt F, Davies S, Kopitz J, Holz FG, Boulton ME. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 2000; 41: 2303-8.
52. Finnemann SC, Leung LW, Rodriguez-Boulan E. The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc Natl Acad Sci USA 2002; 99: 3842-7.
53. Bergmann M, Schütt F, Holz FG, Kopitz J. Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J 2004; 18: 562-4.
54. von Rückmann A, Fitzke FW, Bird AC. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol 1995; 79: 407-12.
55. von Rückmann A, Fitzke FW, Bird AC. In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol 1997; 115: 609-15.
56. von Rückmann A, Fitzke FW, Bird AC. Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci 1997; 38: 478-86.
57. von Rückmann A, Fitzke FW, Bird AC. Distribution of pigment epithelium autofluorescence in retinal disease state recorded in vivo and its change over time. Graefes Arch Clin Exp Ophthalmol 1999; 237: 1-9.
58. Holz FG, Bellmann C, Margaritidis M, Schütt F, Otto TP, Völcker HE. Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1999; 237: 145-52.
59. Schmitz-Valckenberg S, Jorzik JJ, Einbock W et al. for the FAM-Study group. Patterns of abnormal autofluorescence in advanced atrophic ARMD: Classification and Implications for Progression. Invest Ophthalmol Vis Sci 2002; 44: ARVO E-Abstract 2518.
60. Holz FG, Bellmann C, Staudt S, Schürt F, Völcker HE. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci 2001; 42: 1051-6.
61. Einbock W, Moessner A, Schnurrbusch UE, Holz FG, Wolf S. Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study. Graefes Arch Clin Exp Ophthalmol 2005; 243: 300-5.
62. Schmitz-Valckenberg S, Bultmann S, Dreyhaupt J, Bindewald A, Holz FG, Rohrschneider K. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 2004; 45: 4470-6.
63. Bellmann C, Holz FG, Schapp O, Otto TP, Völcker HE. Topographie der Fundusautofluoreszenz mit einem neuen konfokalen Scanning-Laser-Ophthalmoskop. Ophthalmologe 1997; 94: 385-91.
64. Bellmann C, Rubin GS, Kabanarou SA, Bird AC, Fitzke FW. Fundus autofluorescence imaging compared with different confocal scanning laser ophthalmoscopes. Br J Ophthalmol 2003; 87: 1381-6.
65. Lois N, Halfyard AS, Bird AC, Fitzke FW. Quantitative evaluation of fundus autofluorescence imaged "in vivo" in eyes with retinal disease. Br J Ophthalmol 2000; 84: 741-5.
66. Scholl HP, Bellmann C, Dandekar SS, Bird AC, Fitzke FW. Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci 2004; 45: 574-83.
67. Weiter JJ, Delori FC, Wing GL, Fitch KA. Retinal pigment epithelial lipofuscin and melanin and choroidal melanin in human eyes. Invest Ophthalmol Vis Sci 1986; 27: 145-52.
68. Snodderly DM. Evidence for protection against age-related macular degeneration by carotinoids and antioxidant vitamins. Am J Clin Nutr 1995; 62: 1448S-61S.
69. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45: 115-34.
70. Mares-Perlman JA, Brady WE, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 1995; 113: 1518-23.
71. Beatty S, Murray IJ, Henson DB, Carden D, Koh HH, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a northern European population. Invest Ophthalmol Vis Sci 2001; 42: 439-46.
72. Berendschot TJ, Willemse-Assink JJ, Bastiaanse M, de Jong PT, van Norren D. Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 2002; 43: 1928-32.
73. Wüstemeyer H, Moessner A, Jahn C, Wolf S. Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol 2003; 241: 647-51.
74. Trieschmann M, Spital G, Lommatzsch A, et al. Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol 2003; 241: 1006-12.
75. Robson AG, Moreland JD, Pauleikhoff D, et al. Macular pigment density and distribution: comparison of fundus autofluorescence with minimum motion photometry. Vision Res 2003; 43: 1765-75.
76. Delori FC, Pflibsen KP. Spectral reflectance of the human ocular fundus. Appl Opt 1989; 28: 1061-77.
77. Elsner AE, Burns SA, Weiter JJ, Delori FC. Infrared imaging of sub-retinal structures in the human ocular fundus. Vision Res 1996; 36: 191-205.
78. Hartnett ME, Elsner AE. Characteristics of exudative age-related macular degeneration determined in vivo with confocal and indirect infrared imaging. Ophthalmology 1996; 103: 58-71.
79. Manivannan A, Kirkpatrick JN, Sharp PF, Forrester JV. Clinical investigation of an infrared digital scanning laser ophthalmoscope. Br J Ophthalmol 1994; 78: 84-90.
80. Staurenghi G, Aschero M, La Capria A, Gonnella P, Orzalesi N. Visualization of neovascular membranes with infrared light without dye injection by means of a scanning laser ophthalmoscope. Arch Ophthalmol 1996; 114: 365.
81. Mainster MA, Timberlake GT, Webb RH, Hughes GW. Scanning laser ophthalmoscopy. Clinical applications. Ophthalmology 1982; 89: 852-7.
82. Culham LE, Fitzke FW, Timberlake GT, Marshall J. Assessment of fixation stability in normal subjects and patients using a scanning laser ophthalmoscope. Clin Vision Sci 1993; 8: 551-61.
83. Schuchard RA, Fletcher DC. Preferred retinal locus: A review with applications in low vision rehabilitation. Ophthalmol Clin North Am 1994; 7: 243-56.
84. von Noorden GK, Mackensen G. Phenomenology of eccentric fixation. Am J Ophthalmol 1962; 53: 642-61.
85. White JM, Bedell HE. The oculomotor reference in humans with bilateral macular disease. Invest Ophthalmol Vis Sci 1990; 31: 1149-61.
86. Bellmann C, Feely M, Crossland MD, Kabanarou SA, Rubin GS. Fixation stability using central and pericentral fixation targets in patients with age-related macular degeneration. Ophthalmology 2004; 111: 2265-70.
87. Schuchard RA, Raasch TW. Retinal locus for fixation: Pericentral fixation targets. Clin Vision Sci 1992; 7: 511-20.
88. Guez JE, Le Gargasson JF, Rigaudiere F, O'Regan JK. Is there a systematic location for the pseudo-fovea in patients with central scotoma? Vision Res 1993; 33: 1271-9.
89. Timberlake GT, Peli E, Essock EA, Augliere RA. Reading with a macular scotoma. II. Retinal locus for scanning text. Invest Ophthalmol Vis Sci 1987; 28: 1268-74.
90. Culham LE, Fitzke FW, Timberlake GT, Marshall J. Use of scrolled text in a scanning laser ophthalmoscope to assess reading performance at different retinal locations. Ophthalmic Physiol Opt 1992; 12: 281-6.
91. Fletcher DC, Schuchard RA, Livingstone CL, Crane WG, Hu SY. Scanning laser ophthalmoscope macular perimetry and applications for low vision rehabilitation clinicians. Ophthalmol Clin North Am 1994; 7: 257-65.
92. Nilsson UL, Frennesson C, Nilsson SE. Location and stability of a newly established eccentric retinal locus suitable for reading, achieved through training of patients with a dense central scotoma. Optom Vis Sci 1998; 75: 873-8.
93. Nilsson UL, Frennesson C, Nilsson SE. Patients with AMD and a large absolute central scotoma can be trained successfully to use eccentric viewing, as demonstrated in a scanning laser ophthalmoscope. Vision Res 2003; 43: 1777-87.
94. Culham L, Fitzke F, Marshall J. Training of patients with age-related macular disease (AMD) using a scanning laser ophthalmoscope (SLO). Ophthal Physiol Opt 1997; 17: 542.
95. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991; 254: 1178-81.
96. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol 1995; 113: 325-32.
97. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology 1995; 102: 217-29.
98. Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996; 103: 1260-70.
99. Toth CA, Narayan DG, Boppart SA, et al. A comparison of retinal morphology viewed by optical coherence tomography and by light microscopy. Arch Ophthalmol 1997; 115: 1425-8.
100. Rogers AH, Martidis A, Greenberg PB, Puliafito CA. Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization. Am J Ophthalmol 2002; 134: 566-76.
101. Rohrschneider K, Burk RO, Kruse FE, Völcker HE. Reproducibility of the optic nerve head topography with a new laser tomographic scanning device. Ophthalmology 1994; 101: 1044-9.
102. Ang A, Tong L, Vernon SA. Improvement of reproducibility of macular volume measurements using the Heidelberg Retinal Tomograph. Br J Ophthalmol 2000; 84: 1194-7.
103. Asrani S, Zeimer R, Goldberg MF, Zou S. Application of rapid scanning retinal thickness analysis in retinal diseases. Ophthalmology 1997; 104: 1145-51.
104. Bernardes R, Lobo C, Cunha-Vaz JG. Multimodal macula mapping: a new approach to study diseases of the macula. Surv Ophthalmol 2002; 47: 580-9.
105. Polito A, Shah SM, Haller JA, et al. Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease. Am J Ophthalmol 2002; 134: 240-51.
106. Ferguson RD, Hammer DX, Webb RH. A Line-Scanning Laser Ophthalmoscope (LSLO). Invest Ophthalmol Vis Sci 2003; 45: ARVO E-Abstract 3624.
107. Poloschek CM, Rupp V, Krastel H, Holz FG. Multifocal ERG recording with simultaneous fundus monitoring using a confocal scanning laser ophthalmoscope. Eye 2003; 17: 159-66.
108. Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol 2003; 121: 695-706.
109. Podoleanu AG, Dobre GM, Cucu RG, Rosen RB. Combined multiplanar optical coherence tomography and confocal scanning ophthalmoscopy. J Biomed Opt 2004; 9: 86-93.